-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Tracy Cooley
Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.
Latest Posts
Brazil Reaches Beyond Borders to Strengthen STEM Education
The Brazilian government has set an aggressive goal: To train 101,000 Brazilian students and researchers in top universities worldwide in science, technology, engineering and math (STEM) fields by 2014. Launched in 2011, the Science without Borders program is a Brazilian scholarship program, primarily funded by the government of Brazil, that seeks to strengthen and expand science and technology initiatives, innovation and competitiveness through international mobility of undergraduate and graduate students and researchers. Brazilian students and Read More >
2012: A Critical Year for Biotechnology
In 2012, we must continue to look for ways to reduce risk; enhance reward; reduce uncertainty; and reinforce the position of the industry as a major contributor resolving society’s most pressing needs. Policies to encourage investment in innovation and to speed discovery to scientific breakthroughs simply must be the priority in 2012. The industry relies on a policy and regulatory environment that encourages innovation for much needed treatments and cures for some of the most Read More >
Drug Discovery & Development: Partnering for Success…and Survival
There are pressures on Big Pharma and biotech emerging companies alike to engage in more creative deal making to ensure positive outcomes for both parties, Ted Agres writes in Drug Discovery and Development. While the number of deals has remained relatively flat in 2011, the dollar amount of individual deals has increased overall. Oncology remains the most sought after category, followed by CNS, anti-infectives, metabolic diseases, dermatology and cardiovascular. Partnering activity at BIO events is on Read More >
Tap into the Next Generation of Scientists
The importance of mentoring and training students to become scientists has never been more critical as the U.S. aims to maintain its leadership in biotechnology. For students considering a future career path, biotech holds great promise. The industry currently employs 1.42 million Americans in high-wage, high quality jobs while supporting an additional 6.6 million jobs throughout the U.S. On average, biotech jobs pay roughly two-thirds more than the average annual wage of the total U.S. Read More >
BIO Supports SBIR Reauthorization in Senate
Last week, the Senate passed the National Defense Authorization Act (S. 1867), which included SBIR reauthorization through Senate Amendment 1115. This is a critical step toward ensuring that all innovative companies can compete for SBIR grants – based on the promise of their science rather than the structure of their capital. Reauthorizing the program to allow small companies that receive the majority of their financing from venture capital to once again be eligible to compete Read More >
